Association of systemic inflammation markers with the presence and extent of coronary artery calcification

Cytokine

Volumn 57, Issue 2, 2012, Pages 251-257

  Raaz Schrauder, Dorette ^a   Klinghammer, Lutz ^a   Baum, Christina ^a   Frank, Thomas ^a   Lewczuk, Piotr ^a   Achenbach, Stephan ^a   Cicha, Iwona ^a   Stumpf, Christian ^a   Wiltfang, Jens ^a   Kornhuber, Johannes ^a   Daniel, Werner G ^a   Garlichs, Christoph D ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Atherosclerosis; Cardiac computed tomography; Coronary calcification; Cytokines; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CALCIUM; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; UNIVARIATE ANALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; CALCINOSIS; CARDIOMYOPATHIES; CORONARY VESSELS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED;

EID: 84855461980     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.11.015     Document Type: Article

References (36)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
2. Ketteler M., Bongartz P., Westenfeld R., Wildberger J.E., Mahnken A.H., Bohm R., et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003, 361:827-833.
3. Budoff M.J., Achenbach S., Blumenthal R.S., Carr J.J., Goldin J.G., Greenland P., et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 2006, 114:1761-1791.
4. Detrano R., Guerci A.D., Carr J.J., Bild D.E., Burke G., Folsom A.R., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008, 358:1336-1345.
5. Lakoski S.G., Greenland P., Wong N.D., Schreiner P.J., Herrington D.M., Kronmal R.A., et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as " low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med 2007, 167:2437-2442.
6. Pletcher M.J., Tice J.A., Pignone M., Browner W.S. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 2004, 164:1285-1292.
7. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15:827-832.
8. Crouse J.R. Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art. J Lipid Res 2006, 47:1677-1699.
9. Burdon K.P., Langefeld C.D., Beck S.R., Wagenknecht L.E., Carr J.J., Rich S.S., et al. Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). Am Heart J 2006, 151:706-711.
10. Oei H.H., Sayed-Tabatabaei F.A., Hofman A., Oudkerk M., van Duijn C.M., Witteman J.C. The association between angiotensin-converting enzyme gene polymorphism and coronary calcification: the Rotterdam Coronary Calcification Study. Atherosclerosis 2005, 182:169-173.
11. Reilly M.P., Wolfe M.L., Dykhouse J., Reddy K., Localio A.R., Rader D.J. Intercellular adhesion molecule 1 (ICAM-1) gene variant is associated with coronary artery calcification independent of soluble ICAM-1 levels. J Investig Med 2004, 52:515-522.
12. Khera A., de Lemos J.A., Peshock R.M., Lo H.S., Stanek H.G., Murphy S.A., et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 2006, 113:38-43.
13. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Kupka M.J., Manning W.J., et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation 2002, 106:1189-1191.
14. Ait-Oufella H., Taleb S., Mallat Z., Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 2011, 31:969-979.
15. Rumberger J.A., Brundage B.H., Rader D.J., Kondos G. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 1999, 74:243-252.
16. Reilly M.P., Wolfe M.L., Localio A.R., Rader D.J. C-reactive protein and coronary artery calcification: the Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 2003, 23:1851-1856.
17. Jenny N.S., Brown E.R., Detrano R., Folsom A.R., Saad M.F., Shea S., et al. Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2010, 209:226-229.
18. Jialal I., Devaraj S. Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol 2001, 116(Suppl):S108-15.
19. Pearson T.A., Mensah G.A., Hong Y., Smith S.C. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice - overview. Circulation 2004, 110:e543-4.
20. Hansson G.K. Atherosclerosis - an immune disease: the Anitschkov lecture 2007. Atherosclerosis 2009, 202:2-10.
21. Little P.J., Chait A., Bobik A. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis. Pharmacol Ther 2011, 131:255-268.
22. Fisman E.Z., Tenenbaum A. Cardiovascular diabetology: clinical, metabolic and inflammatory facets - preface. Adv Cardiol 2008, 45:xi-xiii.
23. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011, 11:98-107.
24. Koukkunen H., Penttila K., Kemppainen A., Halinen M., Penttila I., Rantanen T., et al. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 2001, 33:37-47.
25. Lee K.W., Lip G.Y., Tayebjee M., Foster W., Blann A.D. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005, 105:526-532.
26. King V.L., Cassis L.A., Daugherty A. Interleukin-4 does not influence development of hypercholesterolemia or angiotensin ii-induced atherosclerotic lesions in mice. Am J Pathol 2007, 171:2040-2047.
27. Davenport P., Tipping P.G. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2003, 163:1117-1125.
28. Folcik V.A., Aamir R., Cathcart M.K. Cytokine modulation of LDL oxidation by activated human monocytes. Arterioscler Thromb Vasc Biol 1997, 17:1954-1961.
29. Saggini A., Maccauro G., Tripodi D., De Lutiis M.A., Conti F., Felaco P., et al. Allergic inflammation: role of cytokines with special emphasis on IL-4. Int J Immunopathol Pharmacol 2011, 24:305-311.
30. May R, Monk P, Cohen E, Manuel D, Dempsey F, Davis N, Dodd A, Corkill D, Woods J, Joberty-Candotti C, Conroy L, Koentgen F, Martin E, Wilson R, Brennan N, Powell J, Anderson I. Preclinical development of CAT-354, an IL-13-neutralising antibody, for the treatment of severe uncontrolled asthma. Br J Pharmacol 2011, in press. doi:10.1111/j.1476-5381.2011.01659.x.
31. Terkeltaub R., Banka C.L., Solan J., Santoro D., Brand K., Curtiss L.K. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler Thromb 1994, 14:47-53.
32. Boekholdt S.M., Peters R.J., Hack C.E., Day N.E., Luben R., Bingham S.A., et al. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 2004, 24:1503-1508.
33. Zhang X., Zhang B., Zhang M., Han Y., Zhao Y., Meng Z., et al. Interleukin-8 gene polymorphism is associated with acute coronary syndrome in the Chinese Han population. Cytokine 2011, 56:188-191.
34. Vogiatzi K., Apostolakis S., Voudris V., Thomopoulou S., Kochiadakis G.E., Spandidos D.A. Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspective. J Clin Immunol 2008, 28:329-335.
35. Qi X., Peng Y., Gu J., Li S., Zheng S., Zhang J., et al. Inflammatory cytokine release in patients with unstable angina after coronary angioplasty. Jpn Heart J 2002, 43:103-115.
36. Godsland I.F., Elkeles R.S., Feher M.D., Nugara F., Rubens M.B., Richmond W., et al. Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study. Diabet Med 2006, 23:1192-1200.